Asia Pacific Molecular Cytogenetics Market Size & Outlook
Asia Pacific molecular cytogenetics market, 2018-2028 (US$M)
Related Markets
Asia Pacific molecular cytogenetics market highlights
- The Asia Pacific molecular cytogenetics market generated a revenue of USD 340.6 million in 2020.
- The market is expected to grow at a CAGR of 13.2% from 2021 to 2028.
- In terms of segment, oncology was the largest revenue generating application in 2020.
- Oncology is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2021 to 2028.
Asia Pacific data book summary
| Market revenue in 2020 | USD 340.6 million |
| Market revenue in 2028 | USD 915.4 million |
| Growth rate | 13.2% (CAGR from 2020 to 2028) |
| Largest segment | Oncology |
| Fastest growing segment | Oncology |
| Historical data covered | 2018 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Genetic Disorders, Oncology, Personalized Medicine, Other Applications |
| Key market players worldwide | Danaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Illumina Inc, Sysmex Corp, Roche Holding AG, BioView, MetaSystems, Agilent Technologies Inc, Revvity Inc |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 20.6% of the global molecular cytogenetics market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 915.4 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Molecular Cytogenetics Market Scope
Molecular Cytogenetics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific molecular cytogenetics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular cytogenetics market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 39.34% in 2020. Horizon Databook has segmented the Asia Pacific molecular cytogenetics market based on genetic disorders, oncology, personalized medicine, other applications covering the revenue growth of each sub-segment from 2018 to 2028.
Factors contributing for to the potential growth in this region are high incident incidence of genetic disorders, & huge geriatric population, rapidly developing infrastructure, large untapped market space, and government initiatives to offer provide better diagnosis for untreatable genetic disorders.
The Government government of Asian countries provides aid for genetic research in teaching hospitals, research facilities, and for penetration of genetic diagnosis to target population. Laboratories practicing commercial testing should be centrally accredited by the according to the framework set by the regulatory bodies and should follow all the protocols to ensure the delivery of quality service.
Moreover, the growing demand for personalized medicine and the rising increasing applications of genetic testing in oncology are certain factors that drive driving the market growth. The diagnostic and biotechnology sector in the Asia- Pacific region has gained momentum, owing to the local presence of major entities.
Reasons to subscribe to Asia Pacific molecular cytogenetics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific molecular cytogenetics market databook
-
Our clientele includes a mix of molecular cytogenetics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific molecular cytogenetics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific molecular cytogenetics market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific molecular cytogenetics market size, by country, 2018-2028 (US$M)
Asia Pacific Molecular Cytogenetics Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
